| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 63,244 | 64,573 | 88,300 | 62,082 | | Cost of Revenue | 28,421 | 28,251 | 26,871 | 26,396 | | | Gross Profit | 34,823 | 36,322 | 61,429 | 35,686 | | | Operating Expenses | | Research Development | 4,596 | 6,833 | 6,097 | 7,724 | | Selling General and Administrative | 17,924 | 21,606 | 19,572 | 21,383 | | Non Recurring | 643 |
-
|
-
|
-
| | Others | 8,285 | 8,295 | 8,265 | 8,421 | | | | Total Operating Expenses | 31,448 |
-
|
-
|
-
| | | | Operating Income or Loss | 4,018 | (412) | 27,495 | (1,842) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 171 | (2,041) | 717 | (67,061) | | Earnings Before Interest And Taxes | 3,546 | (2,453) | 28,212 | (68,903) | | Interest Expense | 9,286 | 9,641 | 10,044 | 10,639 | | Income Before Tax | (5,740) | (12,094) | 18,168 | (79,542) | | Income Tax Expense | 2,062 | (217) | 5,724 | (2,578) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,802) | (11,877) | 12,444 | (76,964) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,802) | (11,877) | 12,444 | (76,964) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,802) | ($11,877) | $12,444 | ($76,964) |
|
0.22% Nasdaq 
Income Statement
